3/4
05:02 pm
cnsp
Form 3 CNS Pharmaceuticals, For: Mar 02 Filed by: Faulkner Eric
Low
Report
Form 3 CNS Pharmaceuticals, For: Mar 02 Filed by: Faulkner Eric
3/4
05:02 pm
cnsp
Form 4 CNS Pharmaceuticals, For: Mar 02 Filed by: Faulkner Eric
Low
Report
Form 4 CNS Pharmaceuticals, For: Mar 02 Filed by: Faulkner Eric
3/4
05:02 pm
cnsp
Form 4 CNS Pharmaceuticals, For: Mar 02 Filed by: O'Loughlin Steve
Low
Report
Form 4 CNS Pharmaceuticals, For: Mar 02 Filed by: O'Loughlin Steve
3/4
05:00 pm
cnsp
Form 3 CNS Pharmaceuticals, For: Mar 02 Filed by: O'Loughlin Steve
Low
Report
Form 3 CNS Pharmaceuticals, For: Mar 02 Filed by: O'Loughlin Steve
3/2
05:00 pm
cnsp
Form 8-K CNS Pharmaceuticals, For: Feb 26
Low
Report
Form 8-K CNS Pharmaceuticals, For: Feb 26
2/27
05:23 pm
cnsp
Form S-8 CNS Pharmaceuticals,
Low
Report
Form S-8 CNS Pharmaceuticals,
2/17
08:36 am
cnsp
Form 8-K CNS Pharmaceuticals, For: Feb 10
Medium
Report
Form 8-K CNS Pharmaceuticals, For: Feb 10
2/13
05:03 pm
cnsp
Form SCHEDULE 13G/A CNS Pharmaceuticals, Filed by: Stonepine Capital Management, LLC
Medium
Report
Form SCHEDULE 13G/A CNS Pharmaceuticals, Filed by: Stonepine Capital Management, LLC
1/2
05:01 pm
cnsp
Form 4 CNS Pharmaceuticals, For: Jan 01 Filed by: Levin Rami
Low
Report
Form 4 CNS Pharmaceuticals, For: Jan 01 Filed by: Levin Rami
1/2
05:00 pm
cnsp
Form 3 CNS Pharmaceuticals, For: Jan 01 Filed by: Levin Rami
Low
Report
Form 3 CNS Pharmaceuticals, For: Jan 01 Filed by: Levin Rami
12/17
08:44 am
cnsp
Form 8-K CNS Pharmaceuticals, For: Dec 16
Medium
Report
Form 8-K CNS Pharmaceuticals, For: Dec 16